2007
DOI: 10.1523/jneurosci.5365-06.2007
|View full text |Cite
|
Sign up to set email alerts
|

Differential Regulation of AMPA Receptor Trafficking by Neurabin-Targeted Synaptic Protein Phosphatase-1 in Synaptic Transmission and Long-Term Depression in Hippocampus

Abstract: Filamentous actin binding protein neurabin I (NrbI) targets protein phosphatase-1 (PP1) to specific postsynaptic microdomains, exerting critical control over AMPA receptor (AMPAR)-mediated synaptic transmission. NrbI-targeted synaptic PP1, which promotes synaptic depression upon long-term depression (LTD) stimuli, serves to prevent synaptic depression under basal conditions. The present studies investigate this opposite regulation of AMPAR trafficking during basal synaptic transmission and LTD by expressing Nr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
82
1

Year Published

2008
2008
2015
2015

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 69 publications
(86 citation statements)
references
References 60 publications
3
82
1
Order By: Relevance
“…After 10 days in vitro, GFP-Rab8 constructs were transfected into the neurons with the calcium phosphate precipitation method as described previously (42). Two days after transfection, the neurons were stained with antibodies recognizing ␣ 2B -AR at a dilution of 1:50 for 1 h at room temperature followed by incubation with Alexa 568-conjugated secondary antibodies for 1 h. Images were acquired using a confocal microscope (Zeiss 510 Meta) as described (43). Data were analyzed by NIH Image J software.…”
Section: Methodsmentioning
confidence: 99%
“…After 10 days in vitro, GFP-Rab8 constructs were transfected into the neurons with the calcium phosphate precipitation method as described previously (42). Two days after transfection, the neurons were stained with antibodies recognizing ␣ 2B -AR at a dilution of 1:50 for 1 h at room temperature followed by incubation with Alexa 568-conjugated secondary antibodies for 1 h. Images were acquired using a confocal microscope (Zeiss 510 Meta) as described (43). Data were analyzed by NIH Image J software.…”
Section: Methodsmentioning
confidence: 99%
“…For example, the serine/threonine protein phosphatase PP1 is enriched in dendritic spines at excitatory synapses (Ouimet et al, 1995;Strack et al, 1999;Terry-Lorenzo et al, 2000), and it controls synaptic plasticity through its ability to dephosphorylate important substrates at the synapse, including Ser845 of the GluA1 -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, and Thr286 of CaM kinase II (Bito et al, 1996;Strack et al, 1997;Genoux et al, 2002;Hsieh-Wilson et al, 2003;Hu et al, 2007), and substrates in the nucleus such as the transcription factor CREB (Bito et al, 1996).…”
Section: Introductionmentioning
confidence: 99%
“…However, the synaptic strength is definitely altered when PP1 interaction with some of these scaffolding proteins is selectively disrupted (Yan et al, 1999;Hu et al, 2007), suggesting that PP1, targeted by different scaffolding proteins, might play distinct or even opposite roles in synaptic responses. In acutely dissociated striatal or neostriatal neurons, disturbing SPN/PP1 interaction blocks the rundown of AMPAR-mediated inward currents generated by application of exogenous kainate (Yan et al, 1999;Feng et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…The supernatant (S1) was collected and centrifuged at 10,000 ϫ g for 15 min to obtain P2 pellet that contained crude synaptosomal fraction. P2 was incubated for 30 min with the lysis buffer containing 0.5% Triton X-100, and then centrifuged at 32,000 ϫ g for 20 min to harvest synaptosomal membrane fraction (P3; Smith et al, 2006;Jaworski et al, 2009;Sanz-Clemente et al, 2010;Li et al, 2015). To assay the protein expression and phosphorylation (Li et al, 2015), the spinal dorsal horn was homogenized in radioimmunoprecipitation assay (RIPA) buffer (50.0 mM Tris-HCl, pH 8.0, 150.0 mM NaCl, 1.0 mM EDTA, 1.0% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate, and proteases/phosphatases inhibitors).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation